Get the Stockscreener App
1.02
0.97%
-0.01
Cocrystal Pharma Inc stock is traded at $1.02, with a volume of 22,775.
It is down -0.97% in the last 24 hours and down -10.53% over the past month.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
See More
Previous Close:
$1.03
Open:
$1.04
24h Volume:
22,775
Relative Volume:
0.66
Market Cap:
$19.65M
Revenue:
$225.00K
Net Income/Loss:
$-8.83M
P/E Ratio:
-1.395
EPS:
-0.7312
Net Cash Flow:
$-8.01M
1W Performance:
-4.67%
1M Performance:
-10.53%
6M Performance:
-35.03%
1Y Performance:
-4.67%
1-Day Range:
$1.01
$1.0598
1-Week Range:
$1.01
$1.1099
52-Week Range:
$0.76
$2.0299
Cocrystal Pharma Inc Stock (COCP) Company Profile
Name
Cocrystal Pharma Inc
Sector
Industry
Phone
(786) 459-1831
Address
19805 N. CREEK PARKWAY, BOTHELL, WA
Compare COCP vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COCP
Cocrystal Pharma Inc
|
1.02 | 19.65M | 225.00K | -8.83M | -8.01M | -0.7312 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-20 | Initiated | H.C. Wainwright | Buy |
Cocrystal Pharma Inc Stock (COCP) Latest News
H.C. Wainwright reiterates Cocrystal Pharma stock rating at buy By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Cocrystal Pharma stock rating at buy By Investing.com - Investing.com Canada
H.C. Wainwright reiterates Cocrystal Pharma stock rating at buy - Investing.com
AIM ImmunoTech Inc. (AIM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Daré Bioscience, Inc. (DARE) stock price, news, quote and history - Yahoo Finance UK
Daré Bioscience, Inc. (DARE) Stock Price, News, Quote & History - ca.finance.yahoo.com
Cocrystal Pharma (COCP) Jumps 8.47% to $1.28 as Biotech Stock Approaches ResistanceHigh Yield Stocks - dars.gov.et
Cocrystal Pharma Completes Dosing in Norovirus Phase 1b Study - TipRanks
Cocrystal Pharma (COCP) Advances Norovirus Antiviral Study Amid High Price-to-Sales Valuation - GuruFocus
Cocrystal Pharma (COCP) finishes dosing human norovirus study, eyes first efficacy readout next - Stock Titan
Cocrystal completes dosing in norovirus drug trial By Investing.com - Investing.com India
Cocrystal completes dosing in norovirus drug trial By Investing.com - Investing.com UK
No serious adverse events reported as a norovirus drug study reaches final dosing - Stock Titan
Cocrystal Pharma (COCP) Jumps 8.47% to $1.28 as Biotech Stock Approaches ResistanceNew Highs New Lows - dars.gov.et
Cocrystal Pharma (COCP) Jumps 8.47% to $1.28 as Biotech Stock Approaches ResistanceLong Setup Ideas - dars.gov.et
symbol__ Stock Quote Price and Forecast - cnn.com
Cocrystal Pharma: The Strategic Reset Investors May Be Missing - Yahoo Finance
Cocrystal Pharma Inc. (COCP) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Cocrystal (COCP) director Brosgart files with zero reported holdings - Stock Titan
COCP: 5 Million Private Placement with OPKO Health - Smartkarma
Cocrystal (COCP) Q1 2026 Results: The EPS Result Is Below Expectation in the Reported Period; After Earnings: The Share Price Adds 0.87%Dividend Increase Stocks - vinanet.vn
Cocrystal Pharma (NasdaqCM:COCP) Stock Forecast & Analyst Predictions - Simply Wall Street
Stock Options: Choosing The Right Viral Inoculum For An Early-Phase Norovirus Trial - Clinical Leader
Cocrystal Pharma appoints Carol L. Brosgart to board of directors By Investing.com - Investing.com South Africa
Cocrystal Pharma appoints Carol L. Brosgart to board of directors By Investing.com - Investing.com South Africa
Form 8K Cocrystal Pharma Inc For: 18 August By Investing.com - Investing.com Nigeria
Cocrystal Pharma appoints Carol L. Brosgart to board of directors By Investing.com - Investing.com India
Cocrystal Pharma appoints Carol L. Brosgart to board of directors - Investing.com
Cocrystal Pharma appoints Carol L. Brosgart to board of directors - Investing.com
Cocrystal Pharma Adds Veteran Leader to Board of Directors - TipRanks
Form 8K Cocrystal Pharma Inc For: 18 August By Investing.com - Investing.com India
Form 8K Cocrystal Pharma Inc For: 18 August By Investing.com - Investing.com Canada
Form 8K Cocrystal Pharma Inc For: 18 August By Investing.com - Investing.com UK
Cocrystal Pharma (NASDAQ: COCP) names Carol L. Brosgart to its board - Stock Titan
Cocrystal Pharma strengthens board with antiviral expert appointment - TipRanks
Cocrystal Pharma appoints Carol Brosgart to board to bolster antiviral development - TradingView
Cocrystal Pharma (COCP) appoints antiviral veteran to board - Stock Titan
Cocrystal Pharma Appoints Antiviral Drug Expert Carol Brosgart to Board - citybiz
Cocrystal Pharma appoints Carol Brosgart to board of directors By Investing.com - Investing.com Nigeria
Cocrystal Pharma appoints Carol Brosgart to board of directors By Investing.com - Investing.com South Africa
Cocrystal Pharma appoints Carol Brosgart to board of directors - Investing.com
Cocrystal Pharma appoints Carol Brosgart to board of directors By Investing.com - Investing.com Canada
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors - The Manila Times
Cocrystal Pharma Appoints Carol Brosgart, M.D. to Board of Directors - Quiver Quantitative
A Gilead veteran joins Cocrystal’s board to guide antiviral drug development - Stock Titan
Cocrystal Pharma Appoints Carol Brosgart, M.D. to Board of Directors - Quiver Quantitative
COCP Q1 2026 Earnings: Wider-than-Expected Loss Costs Share PriceEnergy Earnings Report - careplusvn.com
Cocrystal Pharma Appoints Carol Brosgart, M.D. to Board of Directors - Quiver Quantitative
Cocrystal Pharma Q2 Results: EPS Loss Widens to $(0.23), Misses Estimate - scanx.trade
Cocrystal Pharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cocrystal Pharma Inc Stock (COCP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cocrystal Pharma Inc Stock (COCP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | Director |
Aug 03 '26 |
Buy |
0.94 |
75,000 |
70,590 |
1,983,551 |
| FROST PHILLIP MD ET AL | Director |
Feb 24 '26 |
Buy |
1.00 |
20,000 |
19,952 |
1,908,551 |
| FROST PHILLIP MD ET AL | Director |
Feb 06 '26 |
Buy |
0.95 |
50,000 |
47,280 |
1,888,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 31 '25 |
Buy |
0.95 |
50,000 |
47,275 |
1,838,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 30 '25 |
Buy |
0.97 |
20,000 |
19,310 |
1,788,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 26 '25 |
Buy |
0.97 |
40,000 |
38,944 |
1,768,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 24 '25 |
Buy |
0.97 |
25,000 |
24,258 |
1,728,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 26 '25 |
Buy |
0.99 |
4,000 |
3,975 |
1,703,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 25 '25 |
Buy |
0.94 |
20,000 |
18,812 |
1,699,551 |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):